These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 20938721)
1. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721 [TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-6 and -10 levels in patients with gastric cancer. Ikeguchi M; Hatada T; Yamamoto M; Miyake T; Matsunaga T; Fukumoto Y; Yamada Y; Fukuda K; Saito H; Tatebe S Gastric Cancer; 2009; 12(2):95-100. PubMed ID: 19562463 [TBL] [Abstract][Full Text] [Related]
3. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients. Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852 [TBL] [Abstract][Full Text] [Related]
5. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA. Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. Mroczko B; Groblewska M; Gryko M; Kedra B; Szmitkowski M J Clin Lab Anal; 2010; 24(4):256-61. PubMed ID: 20626020 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101 [TBL] [Abstract][Full Text] [Related]
8. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
9. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer. Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B Dig Dis Sci; 2005 Jun; 50(6):1019-24. PubMed ID: 15986847 [TBL] [Abstract][Full Text] [Related]
10. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
11. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614 [TBL] [Abstract][Full Text] [Related]
12. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284 [TBL] [Abstract][Full Text] [Related]
13. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
15. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection. Liu X; Qiu H; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X Oncotarget; 2016 Jun; 7(23):35446-53. PubMed ID: 27147574 [TBL] [Abstract][Full Text] [Related]
16. A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer. Victorzon M; Haglund C; Lundin J; Roberts PJ Eur J Surg Oncol; 1995 Aug; 21(4):379-84. PubMed ID: 7664902 [TBL] [Abstract][Full Text] [Related]
17. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
18. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
19. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer. Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805 [TBL] [Abstract][Full Text] [Related]
20. Hematopoietic cytokines in the sera of patients with pancreatic cancer. Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]